| Unit name | Developmental Genetics and Embryonal Cancers |
|---|---|
| Unit code | PANM33003 |
| Credit points | 20 |
| Level of study | H/6 |
| Teaching block(s) |
Teaching Block 4 (weeks 1-24) |
| Unit director | Professor. Malik |
| Open unit status | Not open |
| Pre-requisites |
PANM22041 Infection and Immunity PANM22042 Cellular & Molecular Pathology MOLG22100 Recombinant DNA Technology MOLG22200 Gene Expression and Rearrangement FMVS20001 Biomedical Research, Employability and Enterprise Skills |
| Co-requisites |
3 from level 6/H lecture units and Research Skills unit. |
| School/department | School of Cellular and Molecular Medicine |
| Faculty | Faculty of Life Sciences |
This unit will consider molecules, mechanisms and pathways that are critical in regulating early developmental processes. By understanding this, the students will gain an appreciation of how defects and diversions of normal growth control can lead to developmental diseases. In particular, the course will elaborate on aberrations that contribute to carcinogenesis. Lectures will be in weeks 1-4.
This unit will outline how critical molecules, pathways and mechanisms regulate cell growth and development, and examine the pathological consequences of aberrant control. Lectures will expand on understanding:
Knowledge and understanding of the principles of developmental genetics and how defects in normal growth control can lead to embryonal cancers.
Knowledge of the relevant scientific literature and an ability to evaluate this literature critically.
Lectures, Data Handling Session, Tutorial on literature and essay writing.
Independent study: Students are expected to study the recommended literature.
Summative 3 hour written exam, to include 3 essays chose from 6.
Reviews and primary articles from the current scientific literature.
